Lyons, France

David Duracher

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: David Duracher: Innovator in Injectable Solutions

Introduction

David Duracher, a prominent inventor based in Lyons, France, has made significant contributions to the field of pharmaceuticals with his innovative patents. With a portfolio that includes five patents, Duracher is making strides in the development of injectable compositions aimed at improving therapeutic outcomes.

Latest Patents

Duracher's latest patents focus on the creation of injectable aqueous solutions that include amylin, amylin receptor agonists, and co-polyamino acids. His innovative approach involves compositions that maintain a pH range from 6.0 to 8.0, making them suitable for human application. One of his notable patents describes a solution comprised of human glucagon and a co-polyamino acid, again ensuring the same pH specifications. These advancements hold the potential to enhance drug delivery systems and improve the efficacy of treatments.

Career Highlights

Currently, David Duracher is associated with Adocia, a company known for its focus on innovative therapeutic solutions. His work here emphasizes the development of novel compositions that blend effective drug formulation with biocompatibility. The patents he holds not only reflect his deep understanding of pharmaceutical sciences but also his commitment to innovation in this critical field.

Collaborations

David collaborates with prominent colleagues, including Remi Soula and Olivier Soula, to push the boundaries of pharmaceutical innovation. This teamwork fosters a creative environment where new ideas can flourish, leading to advancements that could change the landscape of injectable therapies.

Conclusion

David Duracher stands out as a pioneering inventor in the realm of injectable pharmaceuticals. His work at Adocia, paired with his inventive patents, marks him as an influential figure in the industry. As he continues to explore new horizons in drug formulation, his contributions are sure to have a lasting impact on patient care and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…